Roger Schibli, Head of Center for Radiopharmaceutical Sciences at PSI Paul Scherrer Institut will share his insights on RLT a vision for the future and what’s next in RLT.
Ivana Galetic, SVP Program Management at ARTBIO will talk about Developing RLTs and the challenges and opportunities.
Jeevan Virk, Radioligand Therapy (RLT) Leadership at Novartis will speak about bringing RLT to patients including capacity, logistics and positioning.
Julia Hepp, VP Partnering & Alliances and Michael Pitzner, General Counsel, Senior Vice President Legal and Business Development, both from Molecular Partners will exchange on partnering for RLTs and the BD Landscape.
Don’t miss the chance to connect with industry professionals during our networking apero afterwards.
The event will take place at the Novartis Pavillon, November 28th from 5:30pm - 9:00pm
Registration begins at 5:30 PM — reserve your spot today!